DK115473B - Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-3-benzazepiner eller syreadditionssalte deraf. - Google Patents
Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-3-benzazepiner eller syreadditionssalte deraf.Info
- Publication number
- DK115473B DK115473B DK63068AA DK63068A DK115473B DK 115473 B DK115473 B DK 115473B DK 63068A A DK63068A A DK 63068AA DK 63068 A DK63068 A DK 63068A DK 115473 B DK115473 B DK 115473B
- Authority
- DK
- Denmark
- Prior art keywords
- benzazepines
- tetrahydro
- preparation
- acid addition
- addition salts
- Prior art date
Links
- MWVMYAWMFTVYED-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepine Chemical class C1CNCCC2=CC=CC=C21 MWVMYAWMFTVYED-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Drawers Of Furniture (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH238667A CH481110A (de) | 1967-02-17 | 1967-02-17 | Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen |
| CH1167167A CH488705A (de) | 1967-02-17 | 1967-08-18 | Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK115473B true DK115473B (da) | 1969-10-13 |
Family
ID=25690322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK63068AA DK115473B (da) | 1967-02-17 | 1968-02-16 | Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-3-benzazepiner eller syreadditionssalte deraf. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3652543A (fa) |
| AT (1) | AT275533B (fa) |
| BE (1) | BE710872A (fa) |
| CH (2) | CH481110A (fa) |
| DE (2) | DE1695124A1 (fa) |
| DK (1) | DK115473B (fa) |
| ES (1) | ES350574A1 (fa) |
| FR (2) | FR1561479A (fa) |
| GB (2) | GB1221324A (fa) |
| IL (1) | IL29485A (fa) |
| NL (1) | NL6802257A (fa) |
| NO (1) | NO124369B (fa) |
| SE (1) | SE342043B (fa) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT289812B (de) * | 1968-08-09 | 1971-05-10 | Geigy Ag J R | Verfahren zur Herstellung des neuen 2-Methyl-7-chlor-2,3,4,5-tetrahydro-1H-3-benzazepins sowie seiner Säureadditionssalze |
| DE2016136A1 (de) * | 1970-04-04 | 1971-10-14 | C H Boehnnger Sohn, 6507 Ingel heim | Neue 7 Acyl 1,2,4,5 tetrahydro (3H) 3 benzazepine |
| DE2143204C3 (de) * | 1971-08-28 | 1979-09-27 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | N-Fluoralkyl-phenylisopropylamin-Derivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis |
| DE2207430C3 (de) * | 1972-02-14 | 1982-05-13 | Pennwalt Corp., 19102 Philadelphia, Pa. | 1,2,4,5-Tetrahydro-3H-3-benzazepin, ein Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Mittel |
| EP0161350A1 (en) * | 1981-11-27 | 1985-11-21 | Smithkline Beckman Corporation | Process for preparing benzazepines |
| US4541954A (en) * | 1984-09-05 | 1985-09-17 | Smithkline Beckman Corporation | Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| US5302716A (en) * | 1986-01-16 | 1994-04-12 | Schering Corporation | Fused benzazepines |
| WO1987004430A2 (en) * | 1986-01-16 | 1987-07-30 | Schering Corporation | Fused benzazepines |
| US4973586A (en) * | 1986-01-16 | 1990-11-27 | Schering Corporation | Fused benzazepines, compositions of, and medical use thereof |
| US5015639A (en) * | 1987-03-27 | 1991-05-14 | Schering Corporation | Substituted benzazepines, their preparation and pharmaceutical compositions containing them |
| AU617651B2 (en) * | 1987-07-15 | 1991-12-05 | Schering Corporation | Fused benzazepines |
| AU646432B2 (en) * | 1990-02-02 | 1994-02-24 | Schering Corporation | 4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use |
| US6953787B2 (en) * | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| US20030220661A1 (en) * | 2002-05-21 | 2003-11-27 | Heartstent Corporation | Transmyocardial implant delivery system |
| CA2888392A1 (en) * | 2003-06-17 | 2005-03-03 | Arena Pharmaceuticals, Inc. | Processes for preparing 3-benzazepines |
| EP2332921B1 (en) * | 2003-06-17 | 2016-03-02 | Arena Pharmaceuticals, Inc. | 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride |
| US20070275949A1 (en) * | 2003-10-22 | 2007-11-29 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases |
| WO2005042491A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| EA201200954A1 (ru) | 2004-12-21 | 2013-05-30 | Арена Фармасьютикалз, Инк. | Способ получения полугидрата гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1н-3-бензазепина, фармацевтическая композиция на его основе и его применение |
| RS50997B (sr) | 2004-12-23 | 2010-10-31 | Arena Pharmaceuticals Inc. | Kompozicije 5ht2c receptor modulatora i postupci njihove upotrebe |
| EP2001852A2 (en) | 2006-04-03 | 2008-12-17 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto |
| JP5404414B2 (ja) * | 2006-12-05 | 2014-01-29 | アリーナ ファーマシューティカルズ， インコーポレイテッド | （ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンおよびその中間体を調製するための方法 |
| US8822727B2 (en) * | 2008-03-04 | 2014-09-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| EP2443080A2 (en) | 2009-06-18 | 2012-04-25 | Arena Pharmaceuticals, Inc. | Process for the preparation of 5-ht2c receptor agonists |
| JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
| US9045431B2 (en) | 2010-06-02 | 2015-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| CN103189053A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 用于体重控制的5-ht2c激动剂的调节释放剂型 |
| JP2013539470A (ja) | 2010-09-01 | 2013-10-24 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ロルカセリンと光学活性な酸との塩 |
| SG10201506865WA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Non-hygroscopic salts of 5-ht2c agonists |
| AU2011296015B2 (en) | 2010-09-01 | 2015-11-12 | Arena Pharmaceuticals, Inc. | Administration of lorcaserin to individuals with renal impairment |
| UY34436A (es) | 2012-10-09 | 2014-07-31 | Arena Pharm Inc | Metodo de control del peso |
-
1967
- 1967-02-17 CH CH238667A patent/CH481110A/de not_active IP Right Cessation
- 1967-08-18 CH CH1167167A patent/CH488705A/de not_active IP Right Cessation
-
1968
- 1968-02-15 US US705612A patent/US3652543A/en not_active Expired - Lifetime
- 1968-02-16 GB GB7601/68A patent/GB1221324A/en not_active Expired
- 1968-02-16 DE DE19681695124 patent/DE1695124A1/de active Pending
- 1968-02-16 NO NO0598/68A patent/NO124369B/no unknown
- 1968-02-16 NL NL6802257A patent/NL6802257A/xx unknown
- 1968-02-16 GB GB7600/68A patent/GB1222397A/en not_active Expired
- 1968-02-16 FR FR1561479D patent/FR1561479A/fr not_active Expired
- 1968-02-16 BE BE710872D patent/BE710872A/xx unknown
- 1968-02-16 IL IL29485A patent/IL29485A/xx unknown
- 1968-02-16 DE DE19681668915 patent/DE1668915A1/de active Pending
- 1968-02-16 DK DK63068AA patent/DK115473B/da unknown
- 1968-02-16 ES ES350574A patent/ES350574A1/es not_active Expired
- 1968-02-16 SE SE2047/68A patent/SE342043B/xx unknown
- 1968-02-16 FR FR1560654D patent/FR1560654A/fr not_active Expired
- 1968-02-16 AT AT148868A patent/AT275533B/de active
Also Published As
| Publication number | Publication date |
|---|---|
| NL6802257A (fa) | 1968-08-19 |
| GB1222397A (en) | 1971-02-10 |
| ES350574A1 (es) | 1969-11-16 |
| IL29485A (en) | 1971-07-28 |
| NO124369B (fa) | 1972-04-10 |
| GB1221324A (en) | 1971-02-03 |
| CH481110A (de) | 1969-11-15 |
| DE1695124A1 (de) | 1970-08-20 |
| DE1668915A1 (de) | 1972-03-09 |
| FR1561479A (fa) | 1969-03-28 |
| SE342043B (fa) | 1972-01-24 |
| AT275533B (de) | 1969-10-27 |
| FR1560654A (fa) | 1969-03-21 |
| CH488705A (de) | 1970-04-15 |
| BE710872A (fa) | 1968-08-16 |
| US3652543A (en) | 1972-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK115473B (da) | Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-3-benzazepiner eller syreadditionssalte deraf. | |
| DK130070B (da) | Analogifremgangsmåde til fremstilling af 3,4-dihydroxyphenylalkanolaminer eller syreadditionssalte deraf. | |
| DK108495C (da) | Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner eller syreadditionssalte deraf. | |
| DK123022B (da) | Analogifremgangsmåde til fremstilling af amino-monohalogen-phenylethanolaminer eller syreadditionssalte deraf. | |
| DK124404B (da) | Fremgangsmåde til fremstilling af 2-arylamino-1,3-diazacycloalkener-(2) eller syreadditionssalte deraf. | |
| DK120400B (da) | Analogifremgangsmåde til fremstilling af 1-(3,5-dihalogen-4-hydroxyphenyl)-2-(2-phenoxy- eller 2-phenylalkyl-isopropylamino)-propanoler eller syreadditionssalte deraf. | |
| DK131721B (da) | Analogifremgangsmåde til fremstilling af adamantanylaminer eller 3,5,7-trimethylhomologe eller syreadditionssalte deraf. | |
| DK115846B (da) | Fremgangsmåde til fremstilling af (3,5-diamino-6-halogenpyrazinoyl)guanidin- eller (3,5-diamino-6-halogenpyrazinamido)guanidin-forbindelser eller syreadditionssalte deraf. | |
| DK121367B (da) | Analogifremgangsmåde til fremstilling af 3,3-difenylallylaminderivater eller syreadditionssalte deraf. | |
| DK115851B (da) | Fremgangsmåde til fremstilling af 1,2-dihydro-4-aryl-quinazoliner eller syreadditionssalte deraf. | |
| DK117425B (da) | Fremgangsmåde til fremstilling af heterocyclisk substituerede hydrazino-imidazoliner-(2) eller syreadditionssalte deraf. | |
| DK135231B (da) | Analogifremgangsmåde til fremstilling af basisk substituerede 2,3-cis, trans-diphenylcyclopropanderivater eller syreadditionssalte deraf. | |
| DK118663B (da) | Analogifremgangsmåde til fremstilling af basisk substituerede derivater af 5,6-dihydro-dibenz-[b,e]-azepin-6, 11-dion-11-oxim eller syreadditionssalte deraf. | |
| DK127424B (da) | Analogifremgangsmåde til fremstilling af 4-aryl-1-(4,4-diarylbutyl)-4-hydroxypiperidiner eller syreadditionssalte deraf. | |
| DK118246B (da) | Analogifremgangsmåde til fremstilling af 2-isothiuroniummethyl-3-carboxylsyreamido-quinozalin-di-N-oxid-(1,4)-halogenider. | |
| DK138740B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller syreadditionssalte deraf. | |
| DK127331B (da) | Analogifremgangsmåde til fremstilling af aryloxyisoalkyl-Δ<2>-imidazoliner eller syreadditionssalte heraf. | |
| DK136117B (da) | Fremgangsmåde til fremstilling af 5-hydroxy-5-phenyl-2,3-dihydro-5H-imidazo(2,1-a)-isoindoler eller syreadditionssalte heraf. | |
| DK130587B (da) | Analogifremgangsmåde til fremstilling af difenylpyridazoner eller syreadditionssalt deraf. | |
| DK121125B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller syreadditionssalte deraf. | |
| DK118657B (da) | Analogifremgangsmåde til fremstilling af 3',4',5'-trimethoxy-3-aminoacrylophenoner eller syreadditionssalte deraf. | |
| DK115771B (da) | Fremgangsmåde til fremstilling af (3,5-diamino-6-halogenpyrazinoyl) guanidin- eller (3,5-diamino-6-halogenpyrazinamido) guanidin-forbindelser eller syreadditionssalte deraf. | |
| DK137674B (da) | Analogifremgangsmåde til fremstilling af monophenylsubstituerede oxazoler eller syreadditionssalte deraf. | |
| DK135311B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller syreadditionssalte deraf. | |
| DK126781B (da) | Analogifremgangsmåde til fremstilling af pyrrolidinoguanidinforbindelser eller syreadditionssalte deraf. |